Market Value1,679,836,000
Total Holdings68
File Date2021-02-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CALA / Calithera Biosciences, Inc. Call
NXTC / NextCure, Inc.
AMGN / Amgen Inc. Call
Nextcure, Inc / COMM (00653E112)
Nucana Biomed Ltd / Ordinary Shares (GBOOBYWYV)
Protagonist Therapeutics Inc / COMM (00744E106)
OVID / Ovid Therapeutics Inc.
GWP / GW Pharmaceuticals plc
LLY / Eli Lilly and Company
PDSB / PDS Biotechnology Corporation
OTIC / Otonomy Inc
ATHA / LeonaBio, Inc.
AMGN / Amgen Inc.
ZGNX / Zogenix Inc
CCXI / Churchill Capital Corp XI
PBYI / Puma Biotechnology, Inc.
MRNA / Moderna, Inc. Call
48283N114 / Kadmon Warrants Exp. 09/29/2022
US62857M1053 / MyoKardia, Inc.
FIXX / Homology Medicines, Inc.
US16706W1027 / Chiasma Inc
TCRR / Tcr2 Therapeutics Inc
KURA / Kura Oncology, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
REPL / Replimune Group, Inc.
IMTX / Immatics N.V.
ACRS / Aclaris Therapeutics, Inc.
IOVA / Iovance Biotherapeutics, Inc. Put
BCAB / BioAtla, Inc.
IGMS / IGM Biosciences, Inc.
ALGS / Aligos Therapeutics, Inc.
APTO / Aptose Biosciences Inc.
KDMN / Kadmon Holdings Inc
AGTC / Applied Genetic Technologies Corp
AKUS / Akouos Inc
ZYME / Zymeworks Inc.
XLRN / Acceleron Pharma Inc
ARNA / Arena Pharmaceuticals Inc
LQDA / Liquidia Corporation
ETTX / Entasis Therapeutics Holdings Inc
CGEN / Compugen Ltd.
PTCT / PTC Therapeutics, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
XLV / The Select Sector SPDR Trust - State Street Health Care Select Sector SPDR ETF Put
PTGX / Protagonist Therapeutics, Inc.
FATE / Fate Therapeutics, Inc.
CMPI / Checkmate Pharmaceuticals Inc
CALA / Calithera Biosciences, Inc.
CALA / Calithera Biosciences, Inc. Put
NVCR / NovoCure Limited Call
HZNP / Horizon Therapeutics Plc
ITCI / Intra-Cellular Therapies, Inc.
RETA / Reata Pharmaceuticals Inc - Class A Put
OBSV / ObsEva SA.
JNCE / Jounce Therapeutics Inc
CHRS / Coherus Oncology, Inc.
JAZZ / Jazz Pharmaceuticals plc
UTHR / United Therapeutics Corporation
KRTX / Karuna Therapeutics, Inc.
RGNX / REGENXBIO Inc.
CYTK / Cytokinetics, Incorporated Put
CYTK / Cytokinetics, Incorporated
BCRX / BioCryst Pharmaceuticals, Inc.
MGNX / MacroGenics, Inc.
KNSA / Kiniksa Pharmaceuticals International, plc
MRK / Merck & Co., Inc.
IWM / iShares Trust - iShares Russell 2000 ETF Put
MRUS / Merus N.V.
BMRN / BioMarin Pharmaceutical Inc.
RETA / Reata Pharmaceuticals Inc - Class A
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
GRTX / Galera Therapeutics, Inc.
RCUS / Arcus Biosciences, Inc.
SVRA / Savara Inc.
ABBV / AbbVie Inc.
SUPN / Supernus Pharmaceuticals, Inc.
NCNA / NuCana plc - Depositary Receipt (Common Stock)
YMAB / Y-mAbs Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
SRPT / Sarepta Therapeutics, Inc.
MRNS / Marinus Pharmaceuticals, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
SYBX / Synlogic, Inc.
TGTX / TG Therapeutics, Inc.
INSM / Insmed Incorporated
NTRA / Natera, Inc.
MRNS / Marinus Pharmaceuticals, Inc. Call
INZY / Inozyme Pharma, Inc.
ASND / Ascendis Pharma A/S